Skip to main content
OpenTrials
Completed

NCT Number: NCT03838068

Pulpotomy Technique Preserving Vitality of Traumatized Anterior Permanent Immature Teeth

Aim of the study: To compare the clinical and radiographic outcomes of mineral trioxide aggregate (MTA) and Biodentine as vital pulp therapy materials (pulpotomy) preserving the vitality of traumatized immature anterior permanent teeth.

Materials and Methods: fifty vital traumatized immature anterior permanent teeth exposed with symptomatic /asymptomatic pulpitis were included in the study according to inclusion criteria and were equally divided in two groups. Included teeth were randomly assigned to either a control group (MTA 25 teeth) or a test group (Biodentine 25 teeth). After conducting pulpotomy and covering pulp stumps with the MTA and Biodentine, treated teeth received permanent restorations. Blinded clinical and radiographic evaluations were performed at different time intervals (base line immediate postoperative, 6, 12 and 18 months) according to clinical and radiographic criteria of success. Data were recorded and analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–9 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Gihan Abuelniel

Giza, 12566, Egypt

About this study

Informed consent was obtained from all patients prior to treatment, and patients were offered Root canal treatment in case of treatment failure.

Thirty-three patients who were referred to the postgraduate pediatric dentistry department clinic for the management of their traumatized permanent incisors teeth were assessed. Only Patients who had a traumatic incisor tooth with a vital pulp (detected by clinical signs/symptoms) were included.

Incisors were assigned randomly in the two groups. The MTA group was considered the control group while the biodentine was the test group.

All patients who were clinically eligible for enrollment in the study went through screening pre-operative digital periapical radiographic examination to assess the degree of root development/ formation and any dental infections or anomalies that could interfere with the planned treatment.

The main investigator performed all pulpotomies. Local anesthesia was administrated followed by rubber dam isolation, the coronal pulp tissue was excised to the level of the orifice using a diamond bur with water cooling. Hemostasis was achieved by gentle placement of a saline-moistened cotton pellet over amputated pulps for 5-10 min. Pulp stumps were covered with:

In the first group (control group) white mineral trioxide aggregate (MTA) ProRoot® MTA (Dentsply/ Johnson City,TN,USA) was used as the reference material for comparison and was prepared according to the manufacturer's instructions. A 3-mm-thick layer of MTA was placed over the amputated pulps and was gently adapted to the dentinal walls using a wet cotton pellet deep onto the radicular pulp. A self-cure glass ionomer (GC; GC Corporation, Tokyo, Japan) was placed over the pulpotomy agent before final restoration of composite resin (ClearfilTM, Kuraray, New York, USA) was done.

In the second group Calcium silicate-based BiodentineTM (Septodont Ltd., Saint Maur des Fausse´s, France) was mixed according to the manufacturer's instructions, pulpotomy was performed, radicular pulp was covered, and teeth received self-cure glass ionomer prior to final restoration with the same technique as in the first group.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient age range 7.5-9 years.
  • Noncontributory medical history
  • Unilateral/ and or bilateral central incisors tooth with complicated trauma (exposure size ≥ 1mm)
  • The tooth should give positive response to cold testing
  • Clinical diagnosis of reversible pulpitis without periapical rarefaction
  • The tooth is restorable, mobility was within normal limits
  • No signs of pulpal necrosis including sinus tract or swelling

Exclusion criteria

  • Teeth with mature roots
  • Signs and symptoms of irreversible pulpitis
  • Non-restorable teeth
  • Negative response to cold testing, the presence of sinus tract or swelling
  • No pulp exposure
  • Bleeding could not be controlled after full pulpotomy in 6 minutes

Treatment and study plan

Biodentine

Biological

Biodentine is considered a calcium silicate cement

Other names: Calcium silicate-based

mineral trioxide aggregate

Biological

calcium based silicate cement

Other names: MTA

Cervical pulpotomy

Procedure

coronal pulp tissue was removed till the orifice

Local Anesthetics Procaine

Drug

40 mg/0.01 mg/ml contains sodium metabisulfite and sodium and articaine as an active substance

Other names: artinibsa

Primary outcomes

  1. presence of pain,sensitivity to percussion/ palpation

    Time frame: 18 months

    by asking the patient( questionnaire) (Binary measure) ( Yes or No) where Yes indicates failure of the treatment

  2. Swelling or sinus tract

    Time frame: 18 months

    by visual examination (binary measure)( Yes or No) where Yes indicates clinical failure of the treatment

  3. presence of mobility

    Time frame: 18 months

    by the back of the mirror( Binary measure) (Yes or No) where Yes indicates clinical failure of the treatment.

Secondary outcomes

  1. Stage of root development

    Time frame: 18 months

    by radiographic parallel technique ( four root development stages are assessed E, F,G and H) where E is the worse and H is the best stage.

  2. Presence of radiolucency

    Time frame: 18 months

    by radiographic parallel technique (Binary measure) (Yes or No) where Yes indicates radiographic failure of the treatment.

Sponsors and collaborators

Lead sponsor

Gihan M Abuelniel ,PhD

Other

Collaborators

  • Cairo University

Registry information

Official study title

Clinical and Radiographic Evaluation of Pulpotomy Technique for Preserving Vitality of Traumatized Anterior Permanent Immature Teeth: A Randomized Clinical Trial

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Feb 12, 2019
Registry last updated
Dec 27, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.